Standard Chartered Plc transferred responsibility for risk to Chief Executive Officer Peter Sands from Finance Director Richard Meddings at the request of British regulators, according to a person with knowledge of the matter.
Myriad Genetics Inc. Chief Executive Officer Pete Meldrum says his lab test to pinpoint tumors with a specific genetic mutation could have helped Sanofi-Aventis SA succeed if it had been used in a study of a drug that failed in breast cancer.
Standard Chartered Plc will probably be awarded a banking license in Angola by the end of the year, allowing it to compete with local and Portuguese banks in Africa’s second-biggest oil producer, a central bank official said.
U.S. financial regulators are looking at specific non-bank financial companies to possibly designate them as systemically important and subject to more rigorous supervision, said Michael Gibson, director of the Division of Banking Supervision and Regulation at the Federal Reserve Board.
The following companies may have unusual price changes in Asian trading tomorrow. Stock symbols are in parentheses, and share prices are as of the latest close. The information in each item was released after markets shut unless stated otherwise.
The European Union’s second-highest court upheld a ruling that AstraZeneca Plc misled patent officials and flouted antitrust rules to keep a generic competitor off the market. The court also reduced the associated fine against the company.
AstraZeneca Plc’s need to restock its drug pipeline and boost the lowest valuation in the pharmaceutical industry is turning companies from Amarin Corp. to Forest Laboratories Inc. into takeover candidates.